Regeneron Pharmaceuticals Inc.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

26.36%

Market Cap

61.02 Bil.

P/E Ratio

18.61

Dividend Yield

0.46 %

Earnings per Share

36.77 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE592.3 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 09:57:14 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW592.3585.2
PREV. DAY'S PRICE589.1 (07/20)
CHANGE DAY BEFORE
+3.20
0.54 %
52 WEEK HIGH / LOW700 (01/08)465.2 (07/21)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
32.1635.4436.7740.7648.09
DIVIDENDS PER SHARE
0.000.003.123.293.72
DIVIDEND YIELD IN %
0.00 %0.00 %0.46 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
25.2618.5818.6114.5112.30
PRICE - BOOK RATIO
3.702.662.61--
PRICE - SALES RATIO
7.615.775.84--
PRICE - CASH FLOW RATIO
21.7418.5516.84--
Further Key Figures

Master Data

WKN
881535
ISIN
US75886F1075
SYMBOL
RGO
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Regeneron Pharmaceuticals
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
103.02 Mil.
MARKET CAPITALISATION
61.02 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
1.27 %
11.83 %
-7.26 %
-5.86 %
26.36 %
-9.79 %
19.13 %
-10.66 %
HIGH602.00602.00655.10684.40700.001,087.001,087.00700.00
LOW570.50522.20509.50509.50465.20420.60420.60509.50

Dividende

pro Aktie

Company profile

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.